Symbolbild · KI-generiert
SI-BONE, Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
SI-BONE develops and markets minimally invasive surgical implants for the stabilisation and fusion of the sacroiliac (SI) joint. The products are used in the treatment of chronic back and pelvic pain.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| SI-BONE, Inc. | SIBN | NASDAQ | 788 Mio. USD |
| Solid Biosciences Inc. | SLDB | NASDAQ | 794 Mio. USD |
| SS Innovations International Inc. | SSII | NASDAQ | 797 Mio. USD |
| DBV Technologies S.A. | DBVT | NASDAQ | 799 Mio. USD |
| Kura Oncology, Inc. | KURA | NASDAQ | 800 Mio. USD |
| CCL Industries Inc. Unlimited Class A Voting Shares | CCL.A | TSX | 774 Mio. USD |
| Anteris Technologies Global Corp. | AVR | NASDAQ | 763 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.